Skip to main content
Clinical Trials/ACTRN12618001321235
ACTRN12618001321235
Not yet recruiting
Not Applicable

The role of regenerative medicine for treatment of vulval lichen sclerosus: A randomised control trial of platelet-rich plasma (PRP) versus normal saline

Dr Fariba Behnia Willison0 sites68 target enrollmentAugust 6, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
vulvar lichen sclerosus
Sponsor
Dr Fariba Behnia Willison
Enrollment
68
Status
Not yet recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 6, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Dr Fariba Behnia Willison

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials